| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payments made for deferred purchase price for acquisition | 7,555 | 7,555 |
| Net cash used in financing activities | -88,424 | -73,606 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 74,388 | 41,636 |
| Cash and cash equivalents at beginning of period | 96,612 | - |
| Cash and cash equivalents at end of period | 171,000 | - |
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)